| 查看: 846 | 回复: 7 | ||||
[交流]
STM：靶向作用脂肪激素或可开发出治疗2型糖尿病的新型疗法
|
||||
|
12月23日，来自哈佛大学的一个研究团队通过研究描述了一种临床前的方法或可帮助治疗2型糖尿病、脂肪肝及其它代谢性疾病，文章中研究者开发了一种抗体，其可以改善通过靶向作用脂肪组织中名为aP2（FABP4）的激素来帮助改善机体的葡萄糖调节，并且降低肥胖小鼠集体的脂肪肝症状。 Development of a therapeutic monoclonal antibody that targets secreted fatty acid–binding protein aP2 to treat type 2 diabetes http://stm.sciencemag.org/content/7/319/319ra205 Kill the messenger A variety of metabolic messengers—many from adipose tissue itself—controls the energy state of organs and organisms. Recently, researchers showed that the fatty acid binding protein aP2, once thought to live and work only in the cytoplasm, is also secreted by adipose tissue and spurs metabolic changes in other organs. Now, Burak and colleagues test whether secreted aP2 can serve as a therapeutic target for type 2 diabetes. In mice, the secreted form of aP2 regulates glucose production in liver, systemic glucose homeostasis, and insulin resistance. Serum levels of aP2 were shown to be elevated in obese mice and humans and to correlate with metabolic complications. The authors identified a monoclonal antibody to aP2 that lowered fasting blood glucose, increased insulin sensitivity, and lowered both fat mass and fatty liver (steatosis) in obese mouse models, relative to a control antibody, but not in aP2-deficient mice. The antidiabetic effects of the therapeutic antibody were linked to the regulation of hepatic glucose output and peripheral glucose utilization. Together, these findings suggest that an aP2-targeted antibody that kills the messenger is a viable approach for diabetes treatment. Abstract The lipid chaperone aP2/FABP4 has been implicated in the pathology of many immunometabolic diseases, including diabetes in humans, but aP2 has not yet been targeted for therapeutic applications. aP2 is not only an intracellular protein but also an active adipokine that contributes to hyperglycemia by promoting hepatic gluconeogenesis and interfering with peripheral insulin action. Serum aP2 levels are markedly elevated in mouse and human obesity and strongly correlate with metabolic complications. These observations raise the possibility of a new strategy to treat metabolic disease by targeting serum aP2 with a monoclonal antibody (mAb) to aP2. We evaluated mAbs to aP2 and identified one, CA33, that lowered fasting blood glucose, improved systemic glucose metabolism, increased systemic insulin sensitivity, and reduced fat mass and liver steatosis in obese mouse models. We examined the structure of the aP2-CA33 complex and resolved the target epitope by crystallographic studies in comparison to another mAb that lacked efficacy in vivo. In hyperinsulinemic-euglycemic clamp studies, we found that the antidiabetic effect of CA33 was predominantly linked to the regulation of hepatic glucose output and peripheral glucose utilization. The antibody had no effect in aP2-deficient mice, demonstrating its target specificity. We conclude that an aP2 mAb–mediated therapeutic constitutes a feasible approach for the treatment of diabetes. |
回复此楼» 收录本帖的淘帖专辑推荐
 新药资讯 |
» 猜你喜欢
SUES&NERCN课题组接受硕士生调剂 (学硕1名+专硕1名)
已经有0人回复
-
华南理工大学 基础医学学硕和临床医学学硕调剂
已经有11人回复
-
药理学论文润色/翻译怎么收费?
已经有265人回复
-
北京协和医学院杰青课题组招聘科研助理
已经有0人回复
-
北京协和医学院杰青课题组招聘科研助理
已经有0人回复
-
求助中国药典1995年版、二部
已经有0人回复
-
求大佬收留
已经有0人回复
-
北京协和医学院杰青课题组招聘科研助理
已经有0人回复
-
求助https://www.pnas.org/doi/10.1073/pnas.2535777123 全文
已经有0人回复
-
NSCLC脑转移肿瘤模型
已经有0人回复
-
CHP-134这个细胞系哪里有？
已经有0人回复
» 抢金币啦！回帖就可以得到:
-
【征稿中！】2026年机械、制造技术与材料国际会议 (MEMTM 2026)
+1/649
-
2027级博士研究生——质谱分析
+5/105
-
南京大学医学院附属鼓楼医院 肿瘤疫苗与纳米医学团队 博士后招聘
+1/97
-
上海交通大学周宝文课题组招收2027年申请考核制博士研究生
+1/97
-
武汉大学高等研究院超分子化学与材料课题组2027级招收硕士和博士研究生及研究助理
+1/86
-
复旦大学芯片与系统前沿技术研究院 朱忠赟珅 课题组招收2027级博士研究生
+1/83
-
复旦大学芯片与系统前沿技术研究院 朱忠赟珅 课题组招收2027级博士研究生
+1/82
-
湖南大学电镜中心招收2027年推免直博生
+1/76
-
新加坡国立大学Sibudjing Kawi教授课题组part-time PhD（热催化/等离子体催化方向）
+1/18
-
评职称需要，卖发明专利了:D有技术储备需求的设备厂商可联系
+1/18
-
新加坡国立大学Sibudjing Kawi教授课题组招聘博士后（热催化/等离子体催化方向）
+1/17
-
山东大学-山东字节信息智能技术实验室2026年招聘博士后
+2/16
-
石蜡切片VS冰冻切片：哪种更适合免疫荧光检测？
+1/9
-
中国地质大学（北京）人工智能、电子信息方向招收博士硕士研究生（长期有效）
+1/7
-
西南交通大学力学与航空航天学院 蒋晗 教授课题组招收硕士/博士研究生
+1/7
-
浙江大学招聘2027年生物医学工程直博生
+1/7
-
半导体器件模拟与EDA工具开发及AI大模型本地部署：从器件物理到算力工作站配置方案
+1/4
-
【科研诚信】武汉轻工大学何江玲3篇论文：涉嫌抄袭、成组数据重复、制造虚假显著
+1/3
-
硅纳米颗粒诱导肺损伤相关中性粒细胞胞外诱捕网机制
+1/3
-
结肠炎多维度分子解析：炎症‑免疫‑肠道屏障一体化检测策略
+1/1
8楼2016-01-10 22:43:00
简单回复
jiantu2楼
2015-12-29 10:32
回复
linglingchen(金币+1): 谢谢参与
liangbk3楼
2015-12-29 11:05
回复
linglingchen(金币+1): 谢谢参与
tzynew4楼
2015-12-29 12:50
回复
linglingchen(金币+1): 谢谢参与
假大空5楼
2015-12-29 13:24
回复
linglingchen(金币+1): 谢谢参与
2015-12-29 13:42
回复
linglingchen(金币+1): 谢谢参与
好
2016-01-09 22:32
回复
1
